{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T04:52:24Z","timestamp":1771649544654,"version":"3.50.1"},"reference-count":42,"publisher":"Baishideng Publishing Group Inc.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJC"],"published-print":{"date-parts":[[2009]]},"DOI":"10.4330\/wjc.v1.i1.31","type":"journal-article","created":{"date-parts":[[2010,1,11]],"date-time":"2010-01-11T02:00:55Z","timestamp":1263175255000},"page":"31","source":"Crossref","is-referenced-by-count":12,"title":["Atherosclerosis, inflammation and Chlamydia pneumoniae"],"prefix":"10.4330","volume":"1","author":[{"given":"Giovanni","family":"Fazio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","unstructured":"Zipes DP, Libby P, Bonow RO, Braunwald E, editors . Braunwald's heart disease: a textbook of cardiovascular medicine. 7th ed Philadelphia: Elsevier Saunders; 2005;."},{"key":"ref2","unstructured":"Fazio G, Sutera L, Zito R, Cascio C, Briguglia D, Taormina S, Giammanco A, Assennato P, Novo S. [Rupture of the atherosclerotic plaque: is Chlamydia pneumoniae a possible agent?]. G Ital Cardiol (Rome) 2006;7:809-814."},{"key":"ref3","unstructured":"Lastas A, Graziene V, Barkauskas E, Salkus G, Rimkevicius A. Carotid artery atherosclerotic plaque: clinical and morphological-immunohistochemical correlation. Med Sci Monit 2004;10:CR606-CR614."},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Shishehbor MH, Patel T, Bhatt DL. Using statins to treat inflammation in acute coronary syndromes: Are we there yet? Cleve Clin J Med 2006;73:760-766.","DOI":"10.3949\/ccjm.73.8.760"},{"key":"ref5","unstructured":"Vijayvergiya R. Association of infection with coronary artery disease. Indian J Med Res 2007;125:112-114."},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Yamamoto H, Watanabe T, Miyazaki A, Katagiri T, Idei T, Iguchi T, Mimura M, Kamijima K. High prevalence of Chlamydia pneumoniae antibodies and increased high-sensitive C-reactive protein in patients with vascular dementia. J Am Geriatr Soc 2005;53:583-589.","DOI":"10.1111\/j.1532-5415.2005.53204.x"},{"key":"ref7","unstructured":"Klochkov VA, Dovgalevski\u012d PIa, Umetski\u012d KS, Chalyk NE, Ansimova OM, Zigangirova NA, Petiaev I. [Effect of therapy with antibiotics on lipid metabolism and antioxidant reserve of patients with ischemic heart disease during Chlamydia pneumoniae infection]. Kardiologiia 2005;45:58-61."},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"O'Connor S, Taylor C, Campbell LA, Epstein S, Libby P. Potential infectious etiologies of atherosclerosis: a multifactorial perspective. Emerg Infect Dis 2001;7:780-788.","DOI":"10.3201\/eid0705.010503"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Kinjo K, Sato H, Sato H, Ohnishi Y, Hishida E, Nakatani D, Mizuno H, Ohgitani N, Kubo M, Shimazu T. Joint effects of Chlamydia pneumoniae infection and classic coronary risk factors on risk of acute myocardial infarction. Am Heart J 2003;146:324-330.","DOI":"10.1016\/S0002-8703(03)00150-9"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Sessa R, Di Pietro M, Santino I, del Piano M, Varveri A, Dagianti A, Penco M. Chlamydia pneumoniae infection and atherosclerotic coronary disease. Am Heart J 1999;137:1116-1119.","DOI":"10.1016\/S0002-8703(99)70371-6"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Zairis MN, Papadaki OA, Psarogianni PK, Thoma MA, Andrikopoulos GK, Batika PC, Poulopoulou CG, Trifinopoulou KG, Olympios CD, Foussas SG. Serologic markers of persistent Chlamydia pneumonia infection and long-term prognosis after successful coronary stenting. Am Heart J 2003;146:1082-1089.","DOI":"10.1016\/S0002-8703(03)00503-9"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Wong BY, Gnarpe J, Teo KK, Ohman EM, Prosser C, Gibler WB, Langer A, Chang WC, Armstrong PW. Does chronic Chlamydia pneumoniae infection increase the risk of myocardial injury? Insights from patients with non-ST-elevation acute coronary syndromes. Am Heart J 2002;144:987-994.","DOI":"10.1067\/mhj.2002.126734"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Zebrack JS, Anderson JL. The role of infection in the pathogenesis of cardiovascular disease. Prog Cardiovasc Nurs 2003;18:42-49.","DOI":"10.1111\/j.0889-7204.2003.01421.x"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Aguilar D, Fisher MR, O'Connor CM, Dunne MW, Muhlestein JB, Yao L, Gupta S, Benner RJ, Cook TD, Edwards D. Metabolic syndrome, C-reactive protein, and prognosis in patients with established coronary artery disease. Am Heart J 2006;152:298-304.","DOI":"10.1016\/j.ahj.2005.11.011"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Schmermund A, Möhlenkamp S, Stang A, Grönemeyer D, Seibel R, Hirche H, Mann K, Siffert W, Lauterbach K, Siegrist J. Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf RECALL Study. Risk Factors, Evaluation of Coronary Calcium and Lifestyle. Am Heart J 2002;144:212-218.","DOI":"10.1067\/mhj.2002.123579"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Tousoulis D, Davies G, Stefanadis C, Toutouzas P, Ambrose JA. Inflammatory and thrombotic mechanisms in coronary atherosclerosis. Heart 2003;89:993-997.","DOI":"10.1136\/heart.89.9.993"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995;92:657-671.","DOI":"10.1161\/01.CIR.92.3.657"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Casscells W, Naghavi M, Willerson JT. Vulnerable atherosclerotic plaque: a multifocal disease. Circulation 2003;107:2072-2075.","DOI":"10.1161\/01.CIR.0000069329.70061.68"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Ieven MM, Hoymans VY. Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence. J Clin Microbiol 2005;43:19-24.","DOI":"10.1128\/JCM.43.1.19-24.2005"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Rizzo M, Corrado E, Coppola G, Muratori I, Novo G, Novo S. Prediction of cardio- and cerebro-vascular events in patients with subclinical carotid atherosclerosis and low HDL-cholesterol. Atherosclerosis 2008;200:389-395.","DOI":"10.1016\/j.atherosclerosis.2007.12.020"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Corrado E, Rizzo M, Tantillo R, Muratori I, Bonura F, Vitale G, Novo S. Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: a 5-year follow-up study. Stroke 2006;37:482-486.","DOI":"10.1161\/01.STR.0000198813.56398.14"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Higuchi Mde L, Ramires JA. Infectious agents in coronary atheromas: a possible role in the pathogenesis of plaque rupture and acute myocardial infarction. Rev Inst Med Trop Sao Paulo 2002;44:217-224.","DOI":"10.1590\/S0036-46652002000400007"},{"key":"ref23","unstructured":"Ka\u017amierski R, Podsiad\u0142y E, Tylewska-Wierzbanowska S, Kozubski W. [Association between carotid atherosclerosis, inflammatory markers and Chlamydia pneumoniae infection]. Neurol Neurochir Pol 2005;39:277-286."},{"key":"ref24","unstructured":"Andrié R, Braun P, Welsch U, Straube E, Höpp HW, Erdmann E, Lüderitz B, Bauriedel G. [Chlamydial and human heat shock protein 60 homologues in acute coronary syndromes. (Auto-)immune reactions as a link between infection and atherosclerosis]. Z Kardiol 2003;92:455-465."},{"key":"ref25","unstructured":"Fernández-Miranda C, Paz M, Aranda JL, Fuertes A, Gómez De La Cámara A. [Chronic Chlamydia pneumoniae infection in patients with coronary disease. Relation with increased fibrinogen values]. Med Clin (Barc) 2002;119:561-564."},{"key":"ref26","unstructured":"Paz M, de Otero J, Codinach P, Ferrer-Ruscalleda F, Gayà M, Ibernón M. [Infection and coronary atherosclerosis: the role Chlamydia pneumonia]. Rev Esp Cardiol 1998;51:857-863."},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Wyplosz B, Capron L. [Infectious features of atherosclerosis]. Med Sci (Paris) 2004;20:169-174.","DOI":"10.1051\/medsci\/2004202169"},{"key":"ref28","unstructured":"Ramires JA, Higuchi Mde L. [Mycoplasma pneumoniae and Chlamydia pneumoniae are associated to inflammation and rupture of the atherosclerotic coronary plaques]. Rev Esp Cardiol 2002;55 Suppl 1:2-9."},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"González-Casta\u00f1eda C, Pérez-Castrillón JL, Romero-Gómez M, Herreros-Fernández V. Antibodies against Chlamydia pneumoniae and their relation to lymphocyte population levels. Int J Cardiol 2002;82:293-295.","DOI":"10.1016\/S0167-5273(01)00615-5"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Grayston JT. Background and current knowledge of Chlamydia pneumoniae and atherosclerosis. J Infect Dis 2000;181 Suppl 3:S402-S410.","DOI":"10.1086\/315596"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Kim DK, Kim HJ, Han SH, Lee JE, Moon SJ, Kim BS, Kang SW, Choi KH, Lee HY, Han DS. Chlamydia pneumoniae accompanied by inflammation is associated with the progression of atherosclerosis in CAPD patients: a prospective study for 3 years. Nephrol Dial Transplant 2008;23:1011-8.","DOI":"10.1093\/ndt\/gfm696"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Gattone M, Iacoviello L, Colombo M, Castelnuovo AD, Soffiantino F, Gramoni A, Picco D, Benedetta M, Giannuzzi P. Chlamydia pneumoniae and cytomegalovirus seropositivity, inflammatory markers, and the risk of myocardial infarction at a young age. Am Heart J 2001;142:633-640.","DOI":"10.1067\/mhj.2001.118118"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Mazzoli S, Tofani N, Fantini A, Semplici F, Bandini F, Salvi A, Vergassola R. Chlamydia pneumoniae antibody response in patients with acute myocardial infarction and their follow-up. Am Heart J 1998;135:15-20.","DOI":"10.1016\/S0002-8703(98)70337-0"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Liu R, Yamamoto M, Moroi M, Kubota T, Ono T, Funatsu A, Komatsu H, Tsuji T, Hara H, Hara H. Chlamydia pneumoniae immunoreactivity in coronary artery plaques of patients with acute coronary syndromes and its relation with serology. Am Heart J 2005;150:681-688.","DOI":"10.1016\/j.ahj.2004.11.028"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Zamorano J, García-Tejada J, Suárez A, Culebras E, Casta\u00f1ón J, Moreno R, Reguillo F, Gil M, Picazo J, Sánchez-Harguindey L. Chlamydia pneumoniae in the atherosclerotic plaques of patients with unstable angina undergoing coronary artery bypass grafting: does it have prognostic implications? Int J Cardiol 2003;90:297-302.","DOI":"10.1016\/S0167-5273(02)00573-9"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Higuchi Mde L, Reis MM, Sambiase NV, Palomino SA, Castelli JB, Gutierrez PS, Aiello VD, Ramires JA. Coinfection with Mycoplasma pneumoniae and Chlamydia pneumoniae in ruptured plaques associated with acute myocardial infarction. Arq Bras Cardiol 2003;81:12-22, 1-11.","DOI":"10.1590\/S0066-782X2003000900001"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Hong MK, Mintz GS, Lee CW, Kim YH, Lee SW, Song JM, Han KH, Kang DH, Song JK, Kim JJ. Comparison of coronary plaque rupture between stable angina and acute myocardial infarction: a three-vessel intravascular ultrasound study in 235 patients. Circulation 2004;110:928-933.","DOI":"10.1161\/01.CIR.0000139858.69915.2E"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Fukuda D, Shimada K, Tanaka A, Kusuyama T, Yamashita H, Ehara S, Nakamura Y, Kawarabayashi T, Iida H, Yoshiyama M. Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris. Am J Cardiol 2006;97:175-180.","DOI":"10.1016\/j.amjcard.2005.08.020"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Davidson M, Kuo CC, Middaugh JP, Campbell LA, Wang SP, Newman WP 3rd, Finley JC, Grayston JT. Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis. Circulation 1998;98:628-633.","DOI":"10.1161\/01.CIR.98.7.628"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Liu R, Moroi M, Yamamoto M, Kubota T, Ono T, Funatsu A, Komatsu H, Tsuji T, Hara H, Hara H. Presence and severity of Chlamydia pneumoniae and Cytomegalovirus infection in coronary plaques are associated with acute coronary syndromes. Int Heart J 2006;47:511-519.","DOI":"10.1536\/ihj.47.511"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Zamorano J, Suarez A, Garcia Tejada J, Culebras E, Casta\u00f1ón J, Picazo J, Moreno R, Sanchez-Harguindey L. Prevalence of Chlamydia pneumoniae in the atherosclerotic plaque of patients with unstable angina and its relation with serology. Int J Cardiol 2003;89:273-279.","DOI":"10.1016\/S0167-5273(02)00507-7"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Miya N, Oguchi S, Watanabe I, Kanmatsuse K. Relation of secretory phospholipase A(2) and high-sensitivity C-reactive protein to Chlamydia pneumoniae infection in acute coronary syndromes. Circ J 2004;68:628-633.","DOI":"10.1253\/circj.68.628"}],"container-title":["World Journal of Cardiology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T02:00:42Z","timestamp":1558749642000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1949-8462\/full\/v1\/i1\/31.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.4330\/wjc.v1.i1.31","relation":{},"ISSN":["1949-8462"],"issn-type":[{"value":"1949-8462","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}